Related Experiment Video
Updated: Oct 4, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Could cell division cycle protein 42 be a target for lung cancer treatment?
1Department of Pulmonary and Critical Care Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
Abstract:
Cell division cycle protein 42 (Cdc42), a member of the Rho GTPase family, which is part of the Ras superfamily, plays important roles in multiple fundamental cellular processes. Deregulation of Cdc42 may cause cellular defects that are responsible for the activation of signaling pathways, and such deregulation is related to cancer formation. Lung cancer is one of the most devastating diseases worldwide. Cdc42 is overexpressed in human lung cancer samples, which suggests that this protein is associated with lung carcinogenesis. Herein, we review the functions of Cdc42 in lung cancer and discuss potential pharmacological approaches that target Cdc42 in cancer cells.
Insights
Cell division cycle protein 42 (Cdc42) is overexpressed in lung cancer, driving cancer formation. Targeting Cdc42 offers potential new treatments for lung cancer patients.
Area of Science:
- Molecular biology
- Cell biology
- Oncology
Background:
- Cell division cycle protein 42 (Cdc42) is a Rho GTPase involved in essential cellular functions.
- Aberrant Cdc42 activity contributes to cancer development by activating signaling pathways.
- Lung cancer remains a major global health challenge.
Purpose of the Study:
- To review the role of Cdc42 in lung cancer.
- To explore Cdc42 as a therapeutic target in lung cancer.
Main Methods:
- Literature review of Cdc42 functions in lung cancer.
- Analysis of Cdc42 expression in human lung cancer samples.
Main Results:
- Cdc42 is overexpressed in human lung cancer.
- Cdc42 deregulation is linked to lung carcinogenesis.
- Cdc42 signaling pathways are implicated in lung cancer progression.
Conclusions:
- Cdc42 plays a significant role in lung cancer development.
- Targeting Cdc42 presents a promising strategy for lung cancer therapy.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
Related Concept Videos
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Mitogens and the Cell Cycle